Fundraising FoxAmpersand — 2022 Investments
2 investments dated 2022 · listed companies and verified rows first · show all
AnaBios generates predictive human data for pharmaceutical drug development, using authentic human cells and tissues from healthy and diseased donors to assess drug efficacy and toxicity before clinical trials.
BiotechDeep TechHealthtechSan Diego, US
Andre Ghetti(Chief Executive Officer)inRichard F. Erdman(Director)Paul Miller(Executive Officer)Jack Reynolds(Executive Officer, Director)Peter Crowley(Director)George Goldsmith(Director)
Co-investorsKeiretsu ForumTech Coast Angels
Syft automates multi-channel lead activation by triggering personalized campaigns across email, LinkedIn, Slack, and advertising the moment a qualified prospect is identified.
AdTechData & InfrastructureMarketing TechSaaSSales Tech
Co-investorsAscend Venture CapitalUncommon Projects Capital Management
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.